Clario will become part of Thermo Fisher’s laboratory products and biopharma services segment.

RIDGEFIELD, N.J.-- (BUSINESS WIRE)--Mar 25, 2026-- ...

Thermo Fisher Scientific has completed its acquisition of Clario Holdings for $8.875 billion in cash, plus potential ...

Further strengthens Thermo Fisher’s position as the trusted partner to pharma and biotech customers, delivering important ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts.

FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in ...

Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs top healthcare stocks. On March 3 at the 47th Annual Raymond ...

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-GAAP financial measures such as organic revenue growth, which is ...

Thermo Fisher Scientific TMO is an attractive stock to buy today for several reasons. For one, this wide-moat company generates robust cash flows as the leading supplier in life sciences. In addition, ...

Thermo Fisher ( (TMO)) just unveiled an announcement. On March 24, 2026, Thermo Fisher Scientific announced it had completed the $8.875 billion cash acquisition of Clario Holdings, Inc., a leading ...